Replies to post #15759 on Revive Therapeutics Ltd (RVVTF)

[Ecomike]

This is what got my attention the second time I looked at RVVTF.

Because I already knew about NAC and have been taking it for 3 years.

"The recent publication of the potential of N-acetyl-cysteine (“NAC”) in the treatment of COVID-191 serves as further validation for Bucillamine. NAC has been shown to significantly attenuate clinical symptoms in respiratory viral infections in animals and humans, primarily via donation of thiols to increase antioxidant activity of cellular glutathione.

In comparison, Bucillamine, with its well-established safety record in over 30 years of use in the treatment of rheumatoid arthritis, has been shown to be 16 times more potent as a thiol donor in vivo than NAC. Bucillamine also has the potential, via increasing glutathione activity and other antioxidant and anti-inflammatory activities,2 to lessen the destructive consequences of more advanced SARS CoV2 infections, and attenuate the clinical course of severe COVID-19. "

Great post!!!!!

[RioDad]

Fress,

your whole post, the double down with CEO on Dr. Yo show saying “Good News” should “Come Sooner Than Later....” after discussing the December 31st initial data timeline.

But you are correct....no where but up.